203 related articles for article (PubMed ID: 18829195)
1. Liver metastases of neuroendocrine carcinomas: interventional treatment via transarterial embolization, chemoembolization and thermal ablation.
Vogl TJ; Naguib NN; Zangos S; Eichler K; Hedayati A; Nour-Eldin NE
Eur J Radiol; 2009 Dec; 72(3):517-28. PubMed ID: 18829195
[TBL] [Abstract][Full Text] [Related]
2. Transarterial liver-directed therapies of neuroendocrine hepatic metastases.
Nazario J; Gupta S
Semin Oncol; 2010 Apr; 37(2):118-26. PubMed ID: 20494704
[TBL] [Abstract][Full Text] [Related]
3. Chemoembolization and bland embolization of neuroendocrine tumor metastases to the liver.
Ruutiainen AT; Soulen MC; Tuite CM; Clark TW; Mondschein JI; Stavropoulos SW; Trerotola SO
J Vasc Interv Radiol; 2007 Jul; 18(7):847-55. PubMed ID: 17609443
[TBL] [Abstract][Full Text] [Related]
4. [Chemoperfusion and embolization in the treatment of liver metastases].
Vogl TJ; Mack MG; Eichler K; Zangos S; Naguib NN; Gruber-Rouh T
Rofo; 2011 Jan; 183(1):12-23. PubMed ID: 21113865
[TBL] [Abstract][Full Text] [Related]
5. Review on transarterial chemoembolization in hepatocellular carcinoma: palliative, combined, neoadjuvant, bridging, and symptomatic indications.
Vogl TJ; Naguib NN; Nour-Eldin NE; Rao P; Emami AH; Zangos S; Nabil M; Abdelkader A
Eur J Radiol; 2009 Dec; 72(3):505-16. PubMed ID: 18835117
[TBL] [Abstract][Full Text] [Related]
6. [Transarterial chemoembolization of liver metastases: Indication, technique, results].
Vogl TJ; Zangos S; Balzer JO; Thalhammer A; Mack MG
Rofo; 2002 Jun; 174(6):675-83. PubMed ID: 12063595
[TBL] [Abstract][Full Text] [Related]
7. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival.
Gupta S; Johnson MM; Murthy R; Ahrar K; Wallace MJ; Madoff DC; McRae SE; Hicks ME; Rao S; Vauthey JN; Ajani JA; Yao JC
Cancer; 2005 Oct; 104(8):1590-602. PubMed ID: 16134179
[TBL] [Abstract][Full Text] [Related]
8. Transarterial embolization (TAE) is equally effective and slightly safer than transarterial chemoembolization (TACE) to manage liver metastases in neuroendocrine tumors.
Fiore F; Del Prete M; Franco R; Marotta V; Ramundo V; Marciello F; Di Sarno A; Carratù AC; de Luca di Roseto C; Colao A; Faggiano A
Endocrine; 2014 Sep; 47(1):177-82. PubMed ID: 24385266
[TBL] [Abstract][Full Text] [Related]
9. Extrahepatic disease should not preclude transarterial chemoembolization for metastatic neuroendocrine carcinoma.
Arrese D; McNally ME; Chokshi R; Feria-Arias E; Schmidt C; Klemanski D; Gregory G; Khabiri H; Shah M; Bloomston M
Ann Surg Oncol; 2013 Apr; 20(4):1114-20. PubMed ID: 23456380
[TBL] [Abstract][Full Text] [Related]
10. Hepatic arterial embolization and chemoembolization in the management of patients with large-volume liver metastases.
Kamat PP; Gupta S; Ensor JE; Murthy R; Ahrar K; Madoff DC; Wallace MJ; Hicks ME
Cardiovasc Intervent Radiol; 2008; 31(2):299-307. PubMed ID: 17922160
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinomas 2-3 cm in diameter: transarterial chemoembolization plus radiofrequency ablation vs. radiofrequency ablation alone.
Kim JW; Kim JH; Won HJ; Shin YM; Yoon HK; Sung KB; Kim PN
Eur J Radiol; 2012 Mar; 81(3):e189-93. PubMed ID: 21353417
[TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine hepatic metastases: does aggressive management improve survival?
Touzios JG; Kiely JM; Pitt SC; Rilling WS; Quebbeman EJ; Wilson SD; Pitt HA
Ann Surg; 2005 May; 241(5):776-83; discussion 783-5. PubMed ID: 15849513
[TBL] [Abstract][Full Text] [Related]
13. Transcatheter arterial chemoembolization with or without radiofrequency ablation in the management of patients with advanced hepatic malignancy.
Bloomston M; Binitie O; Fraiji E; Murr M; Zervos E; Goldin S; Kudryk B; Zwiebel B; Black T; Fargher S; Rosemurgy AS
Am Surg; 2002 Sep; 68(9):827-31. PubMed ID: 12356160
[TBL] [Abstract][Full Text] [Related]
14. Metastatic neuroendocrine hepatic tumors: resection improves survival.
Musunuru S; Chen H; Rajpal S; Stephani N; McDermott JC; Holen K; Rikkers LF; Weber SM
Arch Surg; 2006 Oct; 141(10):1000-4; discussion 1005. PubMed ID: 17043278
[TBL] [Abstract][Full Text] [Related]
15. Radiofrequency ablation combined with transarterial chemoembolization for unresectable primary liver cancer.
Wang YH; Liu JF; Li F; Li A; Liu Q; Liu DB; Liu DG; Wang YJ
Chin Med J (Engl); 2009 Apr; 122(8):889-94. PubMed ID: 19493409
[TBL] [Abstract][Full Text] [Related]
16. Bland embolization of hepatocellular carcinoma using superabsorbent polymer microspheres.
Osuga K; Hori S; Hiraishi K; Sugiura T; Hata Y; Higashihara H; Maeda N; Tomoda K; Nakamura H
Cardiovasc Intervent Radiol; 2008; 31(6):1108-16. PubMed ID: 18543028
[TBL] [Abstract][Full Text] [Related]
17. Liver transarterial embolizations in metastatic neuroendocrine tumors.
de Mestier L; Zappa M; Hentic O; Vilgrain V; Ruszniewski P
Rev Endocr Metab Disord; 2017 Dec; 18(4):459-471. PubMed ID: 28975561
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of safety and efficacy for transcatheter arterial chemoembolization alone and plus radiofrequency ablation in the treatment of single branch portal vein tumor thrombus of hepatocellular carcinoma and their prognosis factors].
Zhao M; Wang JP; Li W; Huang ZL; Zhang FJ; Fan WJ; Zhang L; Li XS; Pan CC; Wu PH
Zhonghua Yi Xue Za Zhi; 2011 May; 91(17):1167-72. PubMed ID: 21756768
[TBL] [Abstract][Full Text] [Related]
19. Radiofrequency ablation after transarterial embolization as therapy for patients with unresectable hepatocellular carcinoma.
Liao GS; Yu CY; Shih ML; Chan DC; Liu YC; Yu JC; Chen TW; Hsieh CB
Eur J Surg Oncol; 2008 Jan; 34(1):61-6. PubMed ID: 17434711
[TBL] [Abstract][Full Text] [Related]
20. Combined hepatic arterial embolization and hepatic ablation for unresectable colorectal metastases to the liver.
Fong ZV; Palazzo F; Needleman L; Brown DB; Eschelman DJ; Chojnacki KA; Yeo CJ; Rosato EL
Am Surg; 2012 Nov; 78(11):1243-8. PubMed ID: 23089443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
